Literature DB >> 8942867

The role of postoperative irradiation in the management of sphenoid wing meningiomas. A preliminary report.

K A Peele1, J S Kennerdell, J C Maroon, S Kalnicki, M Kazim, T Gardner, M Malton, T Goodglick, C Rosen.   

Abstract

PURPOSE: To determine whether postoperative radiation therapy decreases recurrence rates in subtotally excised and recurrent sphenoid wing meningiomas.
METHODS: Patients with primary subtotally excised and recurrent sphenoid wing meningiomas who underwent surgery between 1981 and 1994 (n = 105) were prospectively followed for recurrence. Postoperative radiation was not recommended in patients who had complete excision; therefore, their recurrence rates were not evaluated in this study. Patients with malignant meningiomas also were excluded from analysis. Recurrence was defined as evidence of tumor growth on neuroimaging with or without clinical symptoms.
RESULTS: Follow-up information was available for 86 patients; 69 had primary subtotally excised tumors and 17 had recurrent tumors. Follow-up information was unavailable in the remaining 19 patients. Tumor location and histopathology, type of surgery performed, and patient sex and age were similar in the irradiated and nonirradiated subgroups. Postoperative irradiation was delivered to 31 patients with primary tumors and 11 with recurrent tumors; none of these 42 patients had recurrence during a mean observation period of 4.2 and 3.5 years, respectively. The nonirradiated group consisted of 38 patients with primary tumors and 6 with recurrent tumors; 16 of 18 patients who had primary meningiomas had a recurrence and 5 of 6 who had recurrent tumors had another relapse (mean interval between resection and recurrence, 4.4 years and 14 months, respectively).
CONCLUSIONS: Postoperative radiation appeared to delay recurrence in subtotally excised and recurrent sphenoid wing meningiomas during the time frame of this study.

Entities:  

Mesh:

Year:  1996        PMID: 8942867     DOI: 10.1016/s0161-6420(96)30430-2

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  14 in total

1.  Impaired survival and long-term neurological problems in benign meningioma.

Authors:  Hanna van Alkemade; Michelle de Leau; Edith M T Dieleman; Jan W P F Kardaun; Rob van Os; W Peter Vandertop; Wouter R van Furth; Lukas J A Stalpers
Journal:  Neuro Oncol       Date:  2012-03-09       Impact factor: 12.300

Review 2.  Fractionated radiotherapy for intracranial meningiomas.

Authors:  Vinai Gondi; Wolfgang A Tome; Minesh P Mehta
Journal:  J Neurooncol       Date:  2010-09-01       Impact factor: 4.130

Review 3.  Meningiomas: knowledge base, treatment outcomes, and uncertainties. A RANO review.

Authors:  Leland Rogers; Igor Barani; Marc Chamberlain; Thomas J Kaley; Michael McDermott; Jeffrey Raizer; David Schiff; Damien C Weber; Patrick Y Wen; Michael A Vogelbaum
Journal:  J Neurosurg       Date:  2015-01       Impact factor: 5.115

4.  Stereotactic fractionated irradiation of optic nerve sheath meningioma: a new treatment alternative.

Authors:  S Pitz; G Becker; U Schiefer; H Wilhelm; B Jeremic; M Bamberg; E Zrenner
Journal:  Br J Ophthalmol       Date:  2002-11       Impact factor: 4.638

5.  [Sphenoorbital meningiomas: results in long-term treatment].

Authors:  U Schick
Journal:  HNO       Date:  2010-01       Impact factor: 1.284

Review 6.  Radiotherapy and radiosurgery for benign skull base meningiomas.

Authors:  Giuseppe Minniti; Maurizio Amichetti; Riccardo Maurizi Enrici
Journal:  Radiat Oncol       Date:  2009-10-14       Impact factor: 3.481

7.  High-risk Meningioma: Initial Outcomes From NRG Oncology/RTOG 0539.

Authors:  C Leland Rogers; Minhee Won; Michael A Vogelbaum; Arie Perry; Lynn S Ashby; Jignesh M Modi; Anthony M Alleman; James Galvin; Shannon E Fogh; Emad Youssef; Nimisha Deb; Young Kwok; Clifford G Robinson; Hui-Kuo Shu; Barbara J Fisher; Valerie Panet-Raymond; William G McMillan; John F de Groot; Peixin Zhang; Minesh P Mehta
Journal:  Int J Radiat Oncol Biol Phys       Date:  2019-11-29       Impact factor: 7.038

8.  Intermediate-risk meningioma: initial outcomes from NRG Oncology RTOG 0539.

Authors:  Leland Rogers; Peixin Zhang; Michael A Vogelbaum; Arie Perry; Lynn S Ashby; Jignesh M Modi; Anthony M Alleman; James Galvin; David Brachman; Joseph M Jenrette; John De Groot; Joseph A Bovi; Maria Werner-Wasik; Jonathan P S Knisely; Minesh P Mehta
Journal:  J Neurosurg       Date:  2017-10-06       Impact factor: 5.115

9.  Fractionated stereotactic conformal radiotherapy for large benign skull base meningiomas.

Authors:  Giuseppe Minniti; Enrico Clarke; Luigi Cavallo; Mattia Falchetto Osti; Vincenzo Esposito; Gianpaolo Cantore; Paolo Cappabianca; Riccardo Maurizi Enrici
Journal:  Radiat Oncol       Date:  2011-04-12       Impact factor: 3.481

10.  En Plaque Meningiomas: A Narrative Review.

Authors:  Theresa A Elder; Hana Yokoi; A Jessey Chugh; Carlito Lagman; Osmond Wu; Christina Huang Wright; Abhishek Ray; Nicholas Bambakidis
Journal:  J Neurol Surg B Skull Base       Date:  2019-12-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.